RGAHX
Price
$73.85
Change
-$9.79 (-11.70%)
Updated
Dec 18 closing price
TCGLX
Price
$50.90
Change
-$1.56 (-2.97%)
Updated
Dec 18 closing price
Ad is loading...

RGAHX vs TCGLX

Header iconRGAHX vs TCGLX Comparison
Open Charts RGAHX vs TCGLXBanner chart's image
American Funds Growth Fund of Amer R5E
Price$73.85
Change-$9.79 (-11.70%)
VolumeN/A
CapitalizationN/A
Touchstone Large Company Growth C
Price$50.90
Change-$1.56 (-2.97%)
VolumeN/A
CapitalizationN/A
RGAHX vs TCGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGAHX vs. TCGLX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGAHX is a Hold and TCGLX is a Hold.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 313B vs. TCGLX (159M). RGAHX pays higher dividends than TCGLX: RGAHX (0.64) vs TCGLX (0.00). RGAHX was incepted earlier than TCGLX: RGAHX (9 years) vs TCGLX (8 years). TCGLX is a more actively managed with annual turnover of: 44.00 vs. RGAHX (31.00). RGAHX has a lower initial minimum investment than TCGLX: RGAHX (250) vs TCGLX (2500). TCGLX annual gain was more profitable for investors over the last year : 25.22 vs. RGAHX (19.28). RGAHX return over 5 years is better than : 48.17 vs. TCGLX (20.36).
RGAHXTCGLXRGAHX / TCGLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years8 years-
Gain YTD19.03624.51178%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets313B159M196,855%
Annual Yield % from dividends0.640.00-
Returns for 1 year19.2825.2276%
Returns for 3 years5.4712.7443%
Returns for 5 years48.1720.36237%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLTO5.240.05
+1.06%
Galecto Inc
MORN337.50-12.19
-3.49%
Morningstar
PWOD32.16-1.65
-4.88%
Penns Woods Bancorp
VMEO6.46-0.43
-6.24%
Vimeo
APGE44.69-3.40
-7.07%
Apogee Therapeutics